Furthermore, upregulation of SLC7A11 (Fig. 6D) and SLC3A2 (Fig. 6E) proteins was observed in endocrine-resistant breast tumors compared with primary ER+ breast tumors. Here, SLC3A2 is linked to breast neoplasm.